Related Experiment Video
Updated: May 27, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia
Paul C Guest1, Daniel Martins-de-Souza, Natacha Vanattou-Saifoudine
1Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Schizophrenia pathogenesis involves metabolic and hypothalamic-pituitary-adrenal (HPA) axis dysregulation. Understanding these pathways is key for personalized medicine and developing new antipsychotic treatments.
Area of Science:
- Neuroscience
- Psychiatry
- Metabolic research
Background:
- Schizophrenia pathogenesis may involve metabolic and hypothalamic-pituitary-adrenal (HPA) axis disruptions.
- Clinical symptom variability and treatment resistance in schizophrenia patients may stem from these underlying pathway differences.
Purpose of the Study:
- To review existing evidence on metabolic and HPA axis abnormalities in schizophrenia.
- To explore the potential of these findings for improving diagnosis and treatment.
Main Methods:
- Literature review of studies investigating metabolic and HPA axis pathways in schizophrenia.
- Analysis of how these abnormalities relate to clinical presentation and treatment response.
Main Results:
- Evidence suggests significant perturbations in metabolic and HPA axis regulation are associated with schizophrenia.
- These abnormalities correlate with diverse clinical symptoms and variable responses to antipsychotic medications.
Conclusions:
- Abnormalities in metabolism and HPA axis regulation are integral to schizophrenia's complex nature.
- Stratifying patients by molecular phenotype could enable personalized medicine strategies and the development of novel antipsychotic agents.
Related Concept Videos
Hypothalamic-Pituitary Axis
Cushing Syndrome II: Pathophysiology
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychological and Sociocultural Causes of Schizophrenia
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

